LeMaitre Vascular (NSDQ:LMAT) posted third-quarter results that beat the consensus forecast on Wall Street.
The Burlington, Mass.-based company reported profits of $7.5 million, or 37¢ per share, on sales of $36.4 million for the three months ended Sept. 30, for a bottom-line gain of 44.9% sales growth of 25.1% compared with Q3 2019.